Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

RIZATRIPTAN vs ROMIDEPSIN: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

RIZATRIPTAN vs ROMIDEPSIN: Safety Overview

Metric RIZATRIPTAN ROMIDEPSIN
Total FAERS Reports 2,896 1,282
Deaths Reported 68 343
Death Rate 2.3% 26.8%
Hospitalizations 479 458
Average Patient Age 44.6 yrs 64.7 yrs
% Female Patients 77.2% 46.5%
FDA Approval Date Apr 14, 2023 Mar 13, 2020
Manufacturer Panacea Biotec Limited Fresenius Kabi USA, LLC
Route ORAL N/A
Marketing Status Discontinued Prescription